Incipient hypoglycemia triggers a cascade of protective responses, including the suppression of endogenous insulin, stimulation of glucagon secretion, and sympatho-adrenal activation, thus increasing endogenous glucose production and reducing glucose disposal to restore normal glycemia levels. The gene discussed is INS; the disease is Hypoglycemia.